FDA June 4, 2024 5:11 pm

FDA panel votes against use of MDMA therapy for PTSD

A Food and Drug Administration panel voted against the use of MDMA therapy for treatment of post-traumatic stress disorder, NBC Chicago’s Kate Chappell reports.

Local

Exit mobile version